Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative

Mohammad Y. Zaidi,Cecilia G. Ethun,Thuy B. Tran,George A. Poultsides,Valerie P. Grignol,J. Harrison Howard,Meena Bedi,Harveshp Mogal,Jennifer F. Tseng,Kevin K. Roggin,Konstantinos Chouliaras,Konstantinos I. Votanopoulos,Brad Krasnick,Ryan C. Fields,Shervin V. Oskouei,Nickolas B. Reimer,David K. Monson,Shishir K. Maithel,Kenneth Cardona

Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative

2019

Mohammad Y. Zaidi
Cecilia G. Ethun
Thuy B. Tran
George A. Poultsides
Valerie P. Grignol
J. Harrison Howard
Meena Bedi
Harveshp Mogal
Jennifer F. Tseng
Kevin K. Roggin
Konstantinos Chouliaras
Konstantinos I. Votanopoulos
Brad Krasnick
Ryan C. Fields
Shervin V. Oskouei
Nickolas B. Reimer
David K. Monson
Shishir K. Maithel
Kenneth Cardona

Background The role of neoadjuvant chemotherapy (NCT) for high-risk soft tissue sarcoma (STS) is questioned. This study aimed to define which patients may experience a survival advantage with NCT.

Keywords:

General surgery
Radiology
Soft tissue
Medicine
Sarcoma
Chemotherapy
Gastroenterology
Soft tissue sarcoma
Surgical oncology
future studies
Internal medicine
Undifferentiated Pleomorphic Sarcoma
Histology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations